Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo

Clinical Endocrinology

Volumn 65, Issue 6, 2006, Pages 752-759

  Ooi, Esther M M ^a   Watts, Gerald F ^a   Ji, Juying ^a   Rye, Kerry Anne ^b,c,d   Johnson, Anthony G ^e   Chan, Dick C ^a   Barrett, P Hugh R ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b HEART RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LEUCINE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID TRANSFER PROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CELL VACUOLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; GAS CHROMATOGRAPHY; HUMAN; INSULIN RESISTANCE; ISOTOPE LABELING; LIPOPROTEIN METABOLISM; MALE; MASS SPECTROMETRY; MULTIVARIATE ANALYSIS; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN ISOLATION; ULTRACENTRIFUGATION;

ADULT; AGED; BIOLOGICAL MARKERS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; ISOTOPE LABELING; LEUCINE; LIPOPROTEIN(A); LIPOPROTEINS, HDL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHOSPHATIDYLCHOLINES; PHOSPHOLIPID TRANSFER PROTEINS;

EID: 33751098488     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02662.x     Document Type: Article

References (52)

1. Desrumaux, C.M., Mak, P.A., Boisvert, W.A., Masson, D., Stupack, D., Jauhiainen, M., Ehnholm, C. & Curtiss, L.K. (2003) Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells. Journal of Lipid Research, 44, 1453-1461.
2. Oka, T., Kujiraoka, T., Ito, M., Egashira, T., Takahashi, S., Nanjee, M.N., Miller, N.E., Metso, J., Olkkonen, V.M., Ehnholm, C., Jauhiainen, M. & Hattori, H. (2000) Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive. Journal of Lipid Research, 41, 1651-1657.
3. Cao, G., Beyer, T.P., Yang, X.P., Schmidt, R.J., Zhang, Y., Bensch, W.R., Kauffman, R.F., Gao, H., Ryan, T.P., Liang, Y., Eacho, P.I. & Jiang, X.C. (2002) Phospholipid transfer protein is regulated by liver X receptors in vivo. Journal of Biological Chemistry, 277, 39561-39565.
4. Tu, A.Y. & Albers, J.J. (2001) Functional analysis of the transcriptional activity of the mouse phospholipid transfer protein gene. Biochemical and Biophysical Research Communications, 287, 921-926.
5. Tall, A.R., Krumholz, S., Olivecrona, T. & Deckelbaum, R.J. (1985) Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. Journal of Lipid Research, 26, 842-851.
6. van Tol, A. (2002) Phospholipid transfer protein. Current Opinion in Lipidology, 13, 135-139.
7. Jauhiainen, M., Metso, J., Pahlman, R., Blomqvist, S., van Tol, A. & Ehnholm, C. (1993) Human plasma phospholipid transfer protein causes high density lipoprotein conversion. Journal of Biological Chemistry, 268, 4032-4036.
8. Oram, J.F., Wolfbauer, G., Vaughan, A.M., Tang, C. & Albers, J.J. (2003) Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells. Journal of Biological Chemistry, 278, 52379-52385.
9. van Tol, A., Jauhiainen, M., de Crom, R. & Ehnholm, C. (2000) Role of phospholipid transfer protein in high-density lipoprotein metabolism: insights from studies in transgenic mice. International Journal of Tissue Reactions, 22, 79-84.
10. Jiang, X.C., Li, Z., Liu, R., Yang, X.P., Pan, M., Lagrost, L., Fisher, E.A. & Williams, K.J. (2005) Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants. Journal of Biological Chemistry, 280, 18336-18340.
11. Yan, D., Navab, M., Bruce, C., Fogelman, A.M. & Jiang, X.C. (2004) PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity. Journal of Lipid Research, 45, 1852-1858.
12. Riemens, S.C., van Tol, A., Sluiter, W.J. & Dullaart, R.P. (1998) Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese type II diabetic patients. Diabetologia, 41, 929-934.
13. Kaser, S., Sandhofer, A., Foger, B., Ebenbichler, C.F., Igelseder, B., Malaimare, L., Paulweber, B. & Patsch, J.R. (2001) Influence of obesity and insulin sensitivity on phospholipid transfer protein activity. Diabetologia, 44, 1111-1117.
14. Ji, J., Watts, G.F., Johnson, A.G., Chan, D.C., Ooi, E.M., Rye, K.A., Serone, A.P. & Barrett, P.H. (2006) High-density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics. Journal of Clinical Endocrinology and Metabolism, 91, 973-979.
15. Gordon, D.J., Probstfield, J.L., Garrison, R.J., Neaton, J.D., Castelli, W.P., Knoke, J.D., Jacobs, D.R. Jr, Bangdiwala, S. & Tyroler, H.A. (1989) High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation, 79, 8-15.
16. von Eckardstein, A., Huang, Y. & Assmann, G. (1994) Physiological role and clinical relevance of high-density lipoprotein subclasses. Current Opinion in Lipidology, 5, 404-416.
17. Zech, L.A., Schaefer, E.J., Bronzert, T.J., Aamodt, R.L. & Brewer, H.B. Jr (1983) Metabolism of human apolipoproteins A-I and A-II: compartmental models. Journal of Lipid Research, 24, 60-71.
18. Puchois, P., Kandoussi, A., Fievet, P., Fourrier, J.L., Bertrand, M., Koren, E. & Fruchart, J.C. (1987) Apolipoprotein A-I containing lipoproteins in coronary artery disease. Atherosclerosis, 68, 35-40.
19. Barbaras, R., Puchois, P., Fruchart, J.C. & Ailhaud, G. (1987) Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles. Biochemical and Biophysical Research Communications, 142, 63-69.
20. Watts, G.F., Barrett, P.H., Ji, J., Serone, A.P., Chan, D.C., Croft, K.D., Loehrer, F. & Johnson, A.G. (2003) Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome. Diabetes, 52, 803-811.
21. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
22. Tollefson, J.H., Liu, A. & Albers, J.J. (1988) Regulation of plasma lipid transfer by the high-density lipoproteins. American Journal of Physiology, 255, E894-E902.
23. Burstein, M., Scholnick, H.R. & Morfin, R. (1970) Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. Journal of Lipid Research, 11, 583-595.
24. Warnick, G.R. & Albers, J.J. (1978) A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. Journal of Lipid Research, 19, 65-76.
25. 14C]phosphatidylcholine between liposomes and human plasma high density lipoprotein. Partial purification of a transfer-stimulating plasma factor using a rapid transfer assay. Biochimica et Biophysica Acta, 712, 444-452.
26. Baldeweg, S.E., Golay, A., Natali, A., Balkau, B., Del Prato, S. & Coppack, S.W. (2000) Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR). European Journal of Clinical Investigation, 30, 45-52.
27. Schlitt, A., Bickel, C., Thumma, P., Blankenberg, S., Rupprecht, H.J., Meyer, J. & Jiang, X.C. (2003) High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease. Arteriosclerosis, Thrombosis and Vascular Biology, 23, 1857-1862.
28. Huuskonen, J., Ekstrom, M., Tahvanainen, E., Vainio, A., Metso, J., Pussinen, P., Ehnholm, C., Olkkonen, V.M. & Jauhiainen, M. (2000) Quantification of human plasma phospholipid transfer protein (PLTP): relationship between PLTP mass and phospholipid transfer activity. Atherosclerosis, 151, 451-461.
29. Cheung, M.C., Wolfbauer, G., Brown, B.G. & Albers, J.J. (1999) Relationship between plasma phospholipid transfer protein activity and HDL subclasses among patients with low HDL and cardiovascular disease. Atherosclerosis, 142, 201-205.
30. Oomen, P.H., van Tol, A., Hattori, H., Smit, A.J., Scheek, L.M. & Dullaart, R.P. (2005) Human plasma phospholipid transfer protein activity is decreased by acute hyperglycaemia: studies without and with hyperinsulinaemia in type 1 diabetes mellitus. Diabetic Medicine, 22, 768-774.
31. Riemens, S.C., van Tol, A., Sluiter, W.J. & Dullaart, R.P. (1999) Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients. Diabetes, 48, 1631-1637.
32. van Tol, A., Ligtenberg, J.J., Riemens, S.C., van Haeften, T.W., Reitsma, W.D. & Dullaart, R.P. (1997) Lowering of plasma phospholipid transfer protein activity by acute hyperglycaemia-induced hyperinsulinaemia in healthy men. Scandinavian Journal of Clinical and Laboratory Investigation, 57, 147-157.
33. Bouly, M., Masson, D., Gross, B., Jiang, X.C., Fievet, C., Castro, G., Tall, A.R., Fruchart, J.C., Staels, B., Lagrost, L. & Luc, G. (2001) Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate. Journal of Biological Chemistry, 276, 25841-25847.
34. Huuskonen, J., Olkkonen, V.M., Ehnholm, C., Metso, J., Julkunen, I. & Jauhiainen, M. (2000) Phospholipid transfer is a prerequisite for PLTP-mediated HDL conversion. Biochemistry, 39, 16092-16098.
35. Lie, J., de Crom, R., Jauhiainen, M., Van Gent, T., van Haperen, R., Scheek, L., Jansen, H., Ehnholm, C. & van Tol, A. (2001) Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteins. Biochemical Journal, 360, 379-385.
36. Hajj, H.H., Blain, S., Boucher, B., Denis, M., Krimbou, L. & Genest, J. (2005) Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release. Journal of Lipid Research, 46, 1457-1465.
37. Syvanne, M., Castro, G., Dengremont, C., De Geitere, C., Jauhiainen, M., Ehnholm, C., Michelagnoli, S., Franceschini, G., Kahri, J. & Taskinen, M.R. (1996) Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein. Atherosclerosis, 127, 245-253.
38. Rye, K.A., Clay, M.A. & Barter, P.J. (1999) Remodelling of high density lipoproteins by plasma factors. Atherosclerosis, 145, 227-238.
39. Cheung, M.C., Sibley, S.D., Palmer, J.P., Oram, J.F. & Brunzell, J.D. (2003) Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp (A-I) and Lp (A-I,A-II). Journal of Lipid Research, 44, 1552-1558.
40. Pussinen, P.J., Jauhiainen, M. & Ehnholm, C. (1997) ApoA-II/apoAI molar ratio in the HDL particle influences phospholipid transfer protein-mediated HDL interconversion. Journal of Lipid Research, 38, 12-21.
41. Lusa, S., Jauhiainen, M., Metso, J., Somerharju, P. & Ehnholm, C. (1996) The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion. Biochemical Journal, 313, 275-282.
42. Rosseneu, M., Van Tornout, P., Lievens, M.J. & Assmann, G. (1981) Displacement of the human apoprotein A-I by the human apoprotein A-II from complexes of (apoprotein A-I)-phosphatidylcholine-cholesterol. European Journal of Biochemistry, 117, 347-352.
43. Edelstein, C., Halari, M. & Scanu, A.M. (1982) On the mechanism of the displacement of apolipoprotein A-I by apolipoprotein A-II from the high density lipoprotein surface. Effect of concentration and molecular forms of apolipoprotein A-II. Journal of Biological Chemistry, 257, 7189-7195.
44. Tan, K.C., Shiu, S.W., Wong, Y. & Tam, S. (2005) Plasma phospholipid transfer protein activity and subclinical inflammation in type 2 diabetes mellitus. Atherosclerosis, 178, 365-370.
45. Qin, S., Kawano, K., Bruce, C., Lin, M., Bisgaier, C., Tall, A.R. & Jiang, X. (2000) Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins. Journal of Lipid Research, 41, 269-276.
46. Raabe, M., Veniant, M.M., Sullivan, M.A., Zlot, C.H., Bjorkegren, J., Nielsen, L.B., Wong, J.S., Hamilton, R.L. & Young, S.G. (1999) Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. Journal of Clinical Investigation, 103, 1287-1298.
47. Rader, D.J., Castro, G., Zech, L.A., Fruchart, J.C. & Brewer, H.B. Jr (1991) In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II. Journal of Lipid Research, 32, 1849-1859.
48. Aouizerat, B.E., Engler, M.B., Natanzon, Y., Kulkarni, M.V., Song, J., Eng, C., Huuskonen, J., Rivera, C., Poon, A., Bensley, M., Sehnert, A., Zellmer, C., Malloy, M.J., Kane, J.P. & Pullinger, C.R. (2006) Genetic variation of PLTP modulates lipoprotein profiles in hypoalphalipoproteinemia. Journal of Lipid Research, 47, 787-793.
49. Stein, O. & Stein, Y. (2005) Lipid transfer proteins (LTP) and atherosclerosis. Atherosclerosis, 178, 217-230.
50. Jiang, X.C., Qin, S., Qiao, C., Kawano, K., Lin, M., Skold, A., Xiao, X. & Tall, A.R. (2001) Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nature Medicine, 7, 847-852.
51. Urizar, N.L., Dowhan, D.H. & Moore, D.D. (2000) The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. Journal of Biological Chemistry, 275, 39313-39317.
52. Forcheron, F., Cachefo, A., Thevenon, S., Pinteur, C. & Beylot, M. (2002) Mechanisms of the triglyceride- and cholesterol-lowering effect of fenofibrate in hyperlipidemic type 2 diabetic patients. Diabetes, 51, 3486-3491.